Published in Cancer Weekly, June 1st, 1998
Dannielle Lienard represented colleagues from Pasteur Merieux Connaught, France, the University Hospital of Zurich, Switzerland, the Institut Curie, France, and the University Hospital Lausanne, Switzerland, and presented phase I clinical trial data at the 34th Annual Meeting of the American Society of Clinical Oncology, held May 16-19, 1998, in Los Angeles, California (abstract "Intratumoral Administration of Canarypox Virus Expressing Human IL-2 [Interleukin-2] Gene (ALVAC-IL-2) in Cancer Patients: Results of a Phase I Study").
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.